Cover Image
市場調查報告書

行動醫療照護設備的全球市場:各國 (美國·加拿大·印度·中國·日本·英國) 市場,企業簡介,佔有率,趨勢,分析,規模,機會,分類和2015年∼2021年的預測

Global Mobile Healthcare Device Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 345617
出版日期 內容資訊 英文 135 Pages
商品交期: 請詢問到貨日
價格
Back to Top
行動醫療照護設備的全球市場:各國 (美國·加拿大·印度·中國·日本·英國) 市場,企業簡介,佔有率,趨勢,分析,規模,機會,分類和2015年∼2021年的預測 Global Mobile Healthcare Device Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年02月17日 內容資訊: 英文 135 Pages
簡介

近幾年,在合宜的價格之技術創新及生活型態造成疾病的增加,以及智慧手機用戶數增加的背景下,行動醫療照護市場展現出大幅進步,預測2021年行動醫療照護設備市場規模將達到200億美元。

本報告涵括全球行動醫療照護設備市場,從各種角度總括性檢驗推動市場成長要素,阻礙因素,課題,市場機會,市場競爭情形等,並提供現行市場分析與2021年的市場預測。

第1章 摘要整理

第2章 市場概要

  • 序論
  • 行動醫療照護市場主要領域
  • 定義
  • 重要的調查結果
    • 行動醫療照護技術的進步
    • 價格可否合宜是顧慮事項
    • 市場上革新
    • 生活方式造成的疾病增加
    • 新興經濟圈是至今尚未開拓的市場
    • 智慧型手機用戶數的增加
  • 主要的購買標準
    • 可靠性
    • 價格
    • 品牌
  • 價值鏈分析
    • 產品管理
    • 製造及設計
    • 銷售及銷路
    • 連接性
    • 終端用戶/用戶界面
  • 策略性建議
    • 至今應該開拓的亞洲市場
    • 聯盟和合作策略是獲得大眾銷路之策
    • 技術達到急速變化,競爭激烈的市場上需要新技術及革新
    • 成本意識高的亞洲市場上價格成為決策因素
    • 如能提高認知度將可擴大銷售

第3章 市場決策因素

  • 行動醫療照護市場推動市場成長要素
    • 智慧型手機用戶數的全球性增加
    • 生活方式造成的疾病的增加
    • 全球性技術進步
    • 為了維持競爭力的革新
    • 藉由企業聯盟擴大行動醫療照護市場
  • 行動醫療照護市場阻礙市場成長要素
    • 成本高的治療及產品
    • 智慧型手機只佔全行動電話銷售的39%
    • 可靠性的課題
    • 嚴厲的法律規章政策
  • 行動醫療照護市場商務機會
    • 連網型設備市場及應用市場大市場預測擴大
    • 創新的技術
  • 行動醫療照護市場課題
    • 醫療服務的不足
    • 全面行動醫療照護·解決方案的不足
    • 解決生活方式造成的疾病之增加問題
    • 生活方式造成的疾病的流行

第4章 主要企業分析

  • athenahealth
  • Qualcomm Life
  • Telcare
  • Alivcore
  • Voxiva

第5章 競爭力維持的策略

  • 企業聯盟是行動醫療照護市場上的最重要策略
  • 藉由革新與其他競爭企業有所區別
  • 藉由新產品提高企業的關注度
  • 透過企業收購促使雙方的成長
  • 透過合作發展更佳服務
  • 專利相關協定

第6章 市場分類

  • SMBG (血糖自我檢測)設備市場
    • SMBG設備用戶抱的課題
    • SMBG市場頂級品牌
  • 血壓計
    • 血壓計有一定的推動市場成長要素促使需求擴大
    • 高血壓血壓計市場創造商務機會
    • 血壓計市場頂級品牌
  • 神經功能螢幕
  • 心機能力螢幕
  • 睡眠呼吸中止症
  • 脈動式血氧監測儀系統
  • 穿戴式·行動醫療照護設備
    • 心率監測器
  • 其他

第7章 地區市場分析

  • 地區以及各國成長度參數
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
  • 南美
    • 巴西
    • 墨西哥
  • 其他地區
    • 南非

第8章 主要企業簡介

  • Qualcommlife
    • 概要
    • 產品系列
    • 策略性動向
    • SCOT分析
    • 策略性分析
  • athenahealth
  • Apple
  • Voxiva
  • Telcare
  • Motion Computing
  • AliveCor

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HAD-260714

There has been significant progress seen in the mobile healthcare market due to sound and affordable innovative technologies and increase in life style oriented diseases and increase in smartphone users. SMBG, BP monitors, wearable devices and cardiac monitors have been leading the market.

The buying criterion involves reliability, price, quality and brand. The most important aspect of buying in mobile healthcare market is the reliability of the app or device to garner information and take appropriative action. . Mobile healthcare market is growing due to substantial need of patients who are monitored from home.

Companies profiled in this report include

  • 1. Qualcommlife
  • 2. Athenahealth
  • 3. Apple
  • 4. Voxiva
  • 5. Telcare
  • 6. Motion Computing
  • 7. AliveCor

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. Deep profiles top competitive companies

Table of Contents

Chap 1. Executive Summary

Chap 2. Market Overview

  • 2.1. Introduction
  • 2.2. Major segments in mobile healthcare market
  • 2.3. Definition
  • 2.4. Key findings of the report are given below
    • 2.4.1. Advancement in mobile healthcare technology
    • 2.4.2. Affordability is a concern
    • 2.4.3. Innovation in the market
    • 2.4.4. Increase in lifestyle oriented diseases
    • 2.4.5. Untapped market in developing economies
    • 2.4.6. Increase in smartphone users
  • 2.5. Key Buying Criteria
    • 2.5.1. Reliability
    • 2.5.2. Price
    • 2.5.3. Brands
  • 2.6. Value Chain Analysis
    • 2.6.1. Product Management
    • 2.6.2. Manufacturing & Designing
    • 2.6.3. Sales & Distribution
    • 2.6.4. Connectivity
    • 2.6.5. End User/ User Interface
  • 2.7. Strategic Recommendation
    • 2.7.1. Untapped Asian markets to be explored
    • 2.7.2. Partnership and collaboration enable to reach masses
    • 2.7.3. Technology and Innovation is needed in a competitive market place with rapidly changing technology
    • 2.7.4. Prices can be a deciding factor in a cost conscious Asian market
    • 2.7.5. Awareness drives sales

Chap 3. Market Determinants

  • 3.1. Drivers of mobile healthcare market
    • 3.1.1. Global increase in smartphone users
    • 3.1.2. Global increase in lifestyle oriented diseases
      • 3.1.2.1. Diabetic patients have been increasing globally
      • 3.1.2.2. Complications due to diabetes
      • 3.1.2.3. Cardiovascular and other heart diseases
    • 3.1.3. Technological advancement all over the world
      • 3.1.3.1. Technology and mobile healthcare companies go hand in hand
    • 3.1.4. Innovations to stay competitive
      • 3.1.4.1. Some innovation in recent time
    • 3.1.5. Partnership drives the mobile healthcare market
      • 3.1.5.1. Key partnerships in mobile healthcare market
  • 3.2. Restraints of mobile healthcare market
    • 3.2.1. High cost of treatment and products
      • 3.2.1.1. Expensive mobile healthcare technologies
      • 3.2.1.2. High cost of laboratory tests
      • 3.2.1.3. Lingering diseases to incur more cost
      • 3.2.1.4. Affordability and Cost
        • 3.2.1.4.1. Heart rate monitors-
        • 3.2.1.4.2. Cardiac Event Monitors
        • 3.2.1.4.3. Electrocardiogram Machine
        • 3.2.1.4.4. Blood Pressure Monitors
      • 3.2.2. Smartphone account for only 39% of total mobile sales
      • 3.2.3. Reliability issues
        • 3.2.3.1. Some apps under FDA scanner
      • 3.2.4. Stringent regulatory policies
        • 3.2.4.1. FDA and certain guidelines
    • 3.3. Opportunities in mobile healthcare market
      • 3.3.1. Huge scope in connected device and application market
      • 3.3.2. Innovative technologies
        • 3.3.2.1. Innovative technology adds value to the product
    • 3.4. Challenges of Mobile healthcare market
      • 3.4.1. Lack of healthcare services
      • 3.4.2. Lack of inclusive mobile healthcare solutions
      • 3.4.3. Dealing with increasing lifestyle oriented diseases
      • 3.4.4. Prevalence of lifestyle oriented diseases
        • 3.4.4.1. CVD
        • 3.4.4.2. CHD
        • 3.4.4.3. Hypertension
        • 3.4.4.4. Diabetes
        • 3.4.4.5. Revenue analysis of mobile healthcare market

Chap 4. Key company analysis

  • 4.1. athenahealth
  • 4.2. Qualcomm Life
    • 4.2.1. Platform for Qualcomm Life
  • 4.3. Telcare
  • 4.4. Alivcore
  • 4.5. Voxiva

Chap 5. Strategies to stay competitive

  • 5.1. Partnerships are the primary strategies of mobile healthcare market.
    • 5.1.1. Telcare partners with MCM (Medical Cost Management) solutions
  • 5.2. Innovation gives an edge over other competitors
    • 5.2.1. Innovative approach
  • 5.3. New products focus attention on the company
    • 5.3.1. Launch of a product is an important tool
  • 5.4. Acquisition leads to mutual growth
    • 5.4.1. Acquisition in mobile healthcare market
  • 5.5. Collaboration leads to better services
  • 5.6. Patent settlement
    • 5.6.1. Legal issues of patent settlement
    • 5.6.2. Companies make settlement agreement

Chap 6. Market Segmentation

  • 6.1. SMBG device market
    • 6.1.1. Challenges for SMBG device users
    • 6.1.2. Top brands of SMBG market
      • 6.1.2.1. Telcare blood glucose meter
      • 6.1.2.2. Abbott BGM
  • 6.2. BP monitors
    • 6.2.1. Blood pressure monitors are in demand due to certain drivers
    • 6.2.2. High BP creates opportunity in BP market
    • 6.2.3. Top brands of BP market
      • 6.2.3.1. Omron BP monitors
      • 6.2.3.2. Boots BP monitors
      • 6.2.3.3. iHealth Lab BP monitors
  • 6.3. Neurological monitors
    • 6.3.1. Some brands of neurological monitors
      • 6.3.1.1. Codman
      • 6.3.1.2. Camino
  • 6.4. Cardiac monitor
  • 6.5. Sleep apnea
    • 6.5.1. Sleep Apnea is of two types Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA)
      • 6.5.1.1. Type I- Obstructive sleep apnea (OSA)
      • 6.5.1.2. Type II CSA
  • 6.6. Pulse Oximetry
    • 6.6.1. Top brand of pulse oximeters
      • 6.6.1.1. Nellcor
  • 6.7. Wearable mobile healthcare devices
    • 6.7.1. Heart rate monitor
      • 6.7.1.1. Global increase in heart diseases led to heart rate monitors
      • 6.7.1.2. Opportunity created by technology
      • 6.7.1.3. Brief description of heart rate monitor brands
        • 6.7.1.3.1. Polar heart rate monitor
        • 6.7.1.3.2. Garmin heart rate monitors
        • 6.7.1.3.3. AliveCor heart monitors
        • 6.7.1.3.4. Opportunity created due to fitness conscious individuals
  • 6.8. Others
    • 6.8.1. Mental health devices
    • 6.8.2. Cognitive behavior therapy apps
    • 6.8.3. Other mobile healthcare applications
    • 6.8.4. Top brands in mobile healthcare application market
      • 6.8.4.1. Epocrates providing mobile services
      • 6.8.4.2. Voxiva text for health services

Chap 7. Geographical Analysis

  • 7.1. Geographies and growth parameters by countries
  • 7.2. North America
    • 7.2.1. United States (U.S.)
    • 7.2.2. Diabetes in the US
    • 7.2.3. The US regulations (FDA)
  • 7.3. Canada
    • 7.3.1. Disease prevalence in Canada
      • 7.3.1.1. Cardiovascular diseases (CVD)
      • 7.3.1.2. Cancer
      • 7.3.1.3. Diabetes
      • 7.3.1.4. Regulations in Canada
      • 7.3.1.5. Health impact of diabetes
  • 7.4. Europe
    • 7.4.1. Regulations regarding medical devices in Europe
    • 7.4.2. Prevalent diseases in Europe
      • 7.4.2.1. United Kingdom (UK)
      • 7.4.2.2. France
      • 7.4.2.3. Germany
  • 7.5. Asia Pacific
    • 7.5.1. India
      • 7.5.1.1. Regulations in India
      • 7.5.1.2. Diseases prevalent in India
        • 7.5.1.2.1. Cancer
        • 7.5.1.2.2. Hepatitis-B
        • 7.5.1.2.3. HIV
        • 7.5.1.2.4. Opportunities in India
    • 7.5.2. China
      • 7.5.2.1. Diseases prevalent in China
        • 7.5.2.1.1. CVD
        • 7.5.2.1.2. Diabetes
        • 7.5.2.1.3. Regulations in China
    • 7.5.3. Japan
      • 7.5.3.1. Regulation in Japan
        • 7.5.3.1.1. Prevalent diseases in Japan
    • 7.5.4. Korea
      • 7.5.4.1. Prevalent diseases in Korea
        • 7.5.4.1.1. Diabetes
        • 7.5.4.1.2. TB most infectious disease in Korea
        • 7.5.4.1.3. Regulation in Korea
    • 7.5.5. Latin America
      • 7.5.5.1. Brazil
        • 7.5.5.1.1. Regulations in Brazil
        • 7.5.5.1.2. Prevalent diseases in Brazil
          • 7.5.5.1.2.1. Obesity
        • 7.5.5.2. Mexico
          • 7.5.5.2.1. Regulations
          • 7.5.5.2.2. Prevalence of diseases in Mexico
    • 7.5.6. Rest of the World
      • 7.5.6.1. South Africa
        • 7.5.6.1.1. Regulations in South Africa
        • 7.5.6.1.2. Diseases prevalent in South Africa

Chap 8. Company Profiling

  • 8.1. Qualcommlife
    • 8.1.1. Overview
    • 8.1.2. Qualcomm Life products portfolio
    • 8.1.3. Strategic Moves
    • 8.1.4. SCOT Analysis
    • 8.1.5. Strategic analysis
  • 8.2. athenahealth
    • 8.2.1. Overview
    • 8.2.2. athenahealth products portfolio
    • 8.2.3. Strategic Moves
    • 8.2.4. SCOT Analysis
    • 8.2.5. Strategic analysis
  • 8.3. Apple
    • 8.3.1. Overview
    • 8.3.2. Apple Products Portfolio
    • 8.3.3. Revenue Analysis
    • 8.3.4. Strategic Moves
    • 8.3.5. SCOT Analysis
    • 8.3.6. Strategic Analysis
  • 8.4. Voxiva
    • 8.4.1. Overview
    • 8.4.2. Voxiva products portfolio
    • 8.4.3. Strategic Moves
    • 8.4.4. SCOT Analysis
    • 8.4.5. Strategic analysis
  • 8.5. Telcare
    • 8.5.1. Overview
    • 8.5.2. Telcare product portfolio
    • 8.5.3. Strategic Moves
    • 8.5.4. SCOT Analysis
    • 8.5.5. Strategic analysis
  • 8.6. Motion Computing
    • 8.6.1. Overview
    • 8.6.2. Apple Products Portfolio
    • 8.6.3. Strategic Moves
    • 8.6.4. SCOT Analysis
    • 8.6.5. Strategic analysis
  • 8.7. AliveCor
    • 8.7.1. Overview
    • 8.7.2. Alivecor products portfolio
    • 8.7.3. Strategic Moves
    • 8.7.4. SCOT Analysis
    • 8.7.5. Strategic analysis
Back to Top